Výsledky vyhledávání - "Vaguliene, Neringa"

Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXION

Autor: Kloka, Jan, Friedrichson, Benjamin, Dauth, Stephanie, Foldenauer, Ann Christina, Bulczak Schadendorf, Anita, Vehreschild, Maria J. G. T., Matos, Francisco Maio, Riera Mestre, Antoni, Van Asselt, Antoinette D. I., De Robertis, Edoardo, Juskeviciene, Vilma Traskaite, Meybohm, Patrick, Tomescu, Dana, Lacombe, Karine, Stehouwer, Coen D. A., Zacharowski, Kai, Old, Oliver, Ketomaeki, Markus, Grebe, Lea, Booms, Patrick, Lindau, Simone, Zinn, Sebastian, Maushagen, Isabel, Wolf, Timo, Stephan, Christoph, Weynants, Cathy, Daamen, Sylvia, Wülfroth, Petra, Steiner, Thomas, Van Hulst, Marinus, Kranke, Peter, Hottenrott, Sebastian, Schlesinger, Tobias, Schmid, Benedikt, Röder, Daniel, Kranke, Eva, Haas, Tobias, Schlesinger, Philipp, Sitter, Magdalena, Valeri, Davide, Iglesias, Raquel Torres, Mora Luján, José María, Iriarte, Adriana, Cerdà, Pau, Vaguliene, Neringa, Macas, Andrius, Litviniene, Jolanta, Balne, Kristina, Monteiro, Catarina, Ferreira, Inês Antunes, Couceiro, Patrícia, Soares, Pedro, Beirão, Sofia, Aad, Yasmine Abi, Chiarabini, Thibault, Popescu, Mihai, Van Der Kallen, C. J. H., On Behalf Of The Ixion Collaboration Group

Publikováno v: Trials, 23(1):688. BioMed Central Ltd
Dipòsit Digital de la UB
Universidad de Barcelona
TRIALS, 23(1):688. BMC

Background More than 2.7 million hospitalizations of COVID-19-infected patients have occurred in Europe alone since the outbreak of the coronavirus in 2020. Interventions against SARS-CoV-2 are still in high need to prevent admissions to ICUs worldwi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::626db9c12b10dd940342129dd6640c6f
https://doi.org/10.1186/s13063-022-06609-x

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání